Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 12, 1998, Pages 3234-3241

  Tai, Chun Y ^a   Escarpe, Paul A ^a   Sidwell, Robert W ^b   Williams, Matthew A ^a   Lew, Willard ^a   Wu, Huiwei ^a   Kim, Choung U ^a   Mendel, Dirk B ^a  

^a GILEAD SCIENCES   (United States)

^b UTAH STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYL 3 PHENYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; 4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; 4 ACETAMIDO 5 AMINO 3 CYCLOHEXYLOXY 1 CYCLOHEXENE 1 CARBOXYLIC ACID; 4 ACETAMIDO 5 AMINO 3 HEXYLOXY 1 CYCLOHEXENE 1 CARBOXYLIC ACID; 4 ACETAMIDO 5 AMINO 3 OCTYLOXY 1 CYCLOHEXENE 1 CARBOXYLIC ACID; 4 ACETAMIDO 5 AMINO 3 PROPOXY 1 CYCLOHEXENE 1 CARBOXYLIC ACID; 4 ACETAMIDO 5 AMINO 3 SEC BUTOXY 1 CYCLOHEXENE 1 CARBOXYLIC ACID; ANTIVIRUS AGENT; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG; ZANAMIVIR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; INFLUENZA VIRUS; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; VIRUS CULTURE; VIRUS ISOLATION; VIRUS MUTATION; VIRUS VIRULENCE;

EID: 0031787185     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.12.3234     Document Type: Article

References (47)

1. Blick, T. J., T. Tiong, A. Sahasrabudhe, J. N. Varghese, P. M. Colman, G. J. Hart, R. C. Bethell, and J. L. McKimm-Breschkin. 1995. Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2En. Virology 214:475-484.
2. Burmeister, W. P., R. W. Ruigrok, and S. Cusack. 1992. The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. EMBO J. 11:49-56.
3. Burnet, F. M. 1948. Mucins and mucoids in relation to influenza virus action. Aust. J. Exp. Biol. Med. Sci. 26:381-387.
4. Colacino, J. M., N. Y. Chirgadze, E. Garman, E. G. Murti, R. J. Loncharich, A. J. Baxter, K. A. Staschke, and W. G. Laver. 1997. A single sequence change destabilizes the influenza virus neuraminidase tetramer. Virology 236:66-75.
5. Colacino, J. M., W. G. Laver, and G. M. Air. 1997. Selection of influenza A and B viruses for resistance to 4-guanidino-Neu5Ac2en in cell culture. J. Infect. Dis. 176(Suppl. 1):S66-S68.
6. Colman, P. M. 1994. Influenza virus neuraminidase: structure, antibodies, and inhibitors. Protein Sci. 3:1687-1696.
7. 6a. Escarpe, P., and D. Mendel. Unpublished results.
8. Gubareva, L. V., R. Bethell, G. J. Hart, K. G. Murti, C. R. Penn, and R. G. Webster. 1996. Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en. J. Virol. 70:1818-1827.
9. Gubareva, L. V., M. J. Robinson, R. C. Bethell, and R. G. Webster. 1997. Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en. J. Virol. 71: 3385-3390.
10. Hayden, F., K. Cote, and R. G. Douglas, Jr. 1980. Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob. Agents Chemother. 17:865-870.
11. Hayden, F. G., and R. B. Couch. 1992. Clinical and epidemiological importance of influenza A viruses resistant to amantadine and rimantadine. Rev. Med. Virol. 2:89-96.
12. Hayden, F. G., M. Lobo, J. J. Treanor, M. Miller, and R. G. Mills. 1997. Efficacy and tolerability of oral GS 4104 for early treatment of experimental influenza in humans, abstr. LB-14. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
13. Hayden, F. G., A. D. M. E. Osterhaus, J. J. Treanor, D. M. Fleming, F. Y. Aoki, K. G. Nicholson, A. M. Bohnen, H. M. Hirst, O. Keene, and K. Wightman. 1997. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. N. Engl. J. Med. 337:874-880.
14. Hayden, F. G., B. S. Rollins, and L. K. Madren. 1994. Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithelium. Antiviral Res. 25:123-131.
15. Hayden, F. G., J. J. Treanor, A. F. Betts, M. Lobo, J. D. Esinhart, and E. K. Hussey. 1996. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. JAMA 275:295-299.
16. Jedrzejas, M. J., S. Singh, W. J. Brouillette, W. G. Laver, G. M. Air, and M. Luo. 1995. Structures of aromatic inhibitors of influenza virus neuraminidase. Biochemistry 34:3144-3151.
17. Kim, C. U., W. Lew, M. A. Williams, H. Liu, L. Zhang, S. Swaminathan, N. Bischofberger, M. S. Chen, D. B. Mendel, C. Y. Tai, W. G. Laver, and R. C. Stevens. 1997. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J. Am. Chem. Soc. 119:681-690.
18. 16a. Kim, C. U., W. Lew, M. A. Williams, H. Wu, L. Zhang, X. Chen, P. A. Escarpe, D. B. Mendel, W. G. Laver, and R. C. Stevens. 1998. Structure-activity relationship studies of novel carbocyclic in influenza neuraminidase inhibitors. J. Med. Chem. 41:2451-2460.
19. Klenk, H.-D., and R. Rott. 1988. The molecular biology of influenza virus pathogenicity. Adv. Virus Res. 34:247-280.
20. Lin, Y. P., S. A. Wharton, J. Martin, J. J. Skehel, D. C. Wiley, and D. A. Steinhauer. 1997. Adaptation of egg-grown and transfectant viruses for growth in mammalian cells: selection of hemagglutinin mutants with elevated pH of membrane fusion. Virology 233:402-410.
21. Liu, C., M. C. Eichelberger, R. W. Compans, and G. M. Air. 1995. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J. Virol. 69:1099-1106.
22. McKimm-Breschkin, J. L., T. J. Blick, A. Sahasrabudhe, T. Tiong, D. Marshall, G. J. Hart, R. C. Bethell, and C. R. Penn. 1996. Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en. Antimicrob. Agents Chemother. 40:40-46.
23. McKimm-Breschkin, J. L., M. McDonald, T. J. Blick, and P. M. Colman. 1996. Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanidino-Neu5Ac2en leads to instability of the enzyme. Virology 225:240-242.
24. McKimm-Breschkin, J. L., A. Sahasrabudhe, T. J. Blick, M. McDonald, P. M. Colman, G. J. Hart, R. C. Bethell, and J. N. Varghese. 1997. Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors. J. Virol. 72:2456-2462.
25. Mendel, D. B., C. Y. Tai, P. A. Escarpe, W.-X. Li, R. W. Sidwell, J. H. Huffman, C. Sweet, K. J. Jakeman, J. Merson, S. A. Lacy, W. Lew, M. A. Williams, L. Zhang, M. S. Chen, N. Bischofberger, and C. U. Kim. 1998. Oral administration of a prodrug of the influenza neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection. Antimicrob. Agents Chemother. 42:640-646.
26. Monto, A. S., I. A. Iacuzio, and J. R. LaMontague. 1997. Pandemic influenza: confronting a reemergent threat. J. Infect. Dis. 176(Suppl. 1):51-53.
27. Monto, A. S., and N. H. Arden. 1992. Implications of viral resistance to amantadine in control of influenza A. Clin. Infect. Dis. 15:362-367.
28. Oxford, J. S., I. S. Logan, and C. W. Potter. 1970. Passage of influenza strains in the presence of aminoadamantane. Ann. N. Y. Acad. Sci. 173:300-313.
29. Palese, P., and R. W. Compans. 1976. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J. Gen. Virol. 33:159-163.
30. Palese, P., K. Tobita, M. Ueda, and R. W. Compans. 1974. Characterization of temperature sensitive influenza virus mutants. Virology 61:397-410.
31. Penn, C. R., J. M. Barnett, R. C. Bethell, R. Fenton, K. L. Gearing, N. Healy, and A. J. Jowett. 1996. Selection of influenza virus with reduced sensitivity in vitro to the neuraminidase inhibitor GG167 (4-guanidino-Neu5Ac2en): changes in haemagglutinin may compensate for loss of neuraminidase activity, p. 735-740. In L. E. Brown, A. W. Hampson, and R. G. Webster (ed.), Options for the control of influenza III. Elsevier, Amsterdam, The Netherlands.
32. Potier, M., L. Mameli, M. Bélisle, L. Dallaire, and S. B. Melançon. 1979. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-D-N-acetylneuraminate) substrate. Anal. Biochem. 94:287-296.
33. Ryan, D. M., J. Ticehurst, and M. H. Dempsey. 1995. GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is a potent inhibitor of influenza virus in ferrets. Antimicrob. Agents Chemother. 39:2583-2584.
34. Ryan, D. M., J. Ticehurst, M. H. Dempsey, and C. R. Penn. 1994. Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase). Antimicrob. Agents Chemother. 38:2270-2275.
35. Sahasrabudhe, A., T. Blick, and J. McKimm-Breschkin. 1996. Influenza virus variants resistant to GG167 with mutations in the haemagglutinin, p. 748-752. In L. E. Brown, A. W. Hampson, and R. G. Webster (ed.), Options for the control of influenza III. Elsevier, Amsterdam, The Netherlands.
36. Sidwell, R. W., J. H. Huffman, D. L. Barnard, K. W. Bailey, M.-H. Wong, A. Morrison, T. Syndergaard, and C. U. Kim. 1998. Inhibition of influenza A virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor. Antiviral Res., 37:107-120.
37. Sidwell, R. W., J. H. Huffman, E. W. Call, H. Alaghamandaan, P. D. Cook, and R. K. Robins. 1986. Effect of selenazofurin on influenza A and B virus infections of mice. Antiviral Res. 6:343-353.
38. Smith, P. W., S. L. Sollis, P. D. Howes, P. C. Cherry, K. N. Cobley, H. Taylor, A. R. Whittington, J. Scicinski, R. C. Bethell, N. Taylor, T. Skarzynski, A. Cleasby, O. Singh, A. Wonacott, J. Varghese, and P. Colman. 1996. Novel inhibitors of influenza sialidases related to GG167. Structure-activity, crystallographic and molecular dynamic studies with 4H-pyran-2-carboxylic acid 6-carboxamides. Bioorg. Med. Chem. Lett. 6:2931-2936.
39. Sollis, S. L., P. W. Smith, P. D. Howes, P. C. Cherry, and R. C. Bethell. 1996. Novel inhibitors of influenza sialidase related to GG167 synthesis of 4-amino and guanidino-4H-pyran-2-carboxylic acid-6-propylamides; selective inhibitors of influenza A virus sialidase. Bioorg. Med. Chem. Lett. 6:1805-1808.
40. Staschke, K. A., J. M. Colacino, A. J. Baxter, G. M. Air, A. Bansal, W. J. Hornback, J. E. Munroe, and W. G. Laver. 1995. Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2En. Virology 214: 642-646.
41. Subbarao, K., A. Klimov, J. Katz, H. Regnery, W. Lim, H. Hall, M. Perdue, D. Swayne, C. Bender, J. Huang, M. Hemphill, T. Rowe, M. Shaw, X. Xu, K. Fukuda, and N. Cox. 1998. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279:393-396.
42. Thomas, G. P., M. Forsyth, C. R. Penn, and J. W. McCauley. 1994. Inhibition of the growth of influenza viruses in vitro by 4-guanidino-2,4-dideoxy-N-acetylneuraminic acid. Antiviral Res. 24:351-356.
43. Varghese, J. N., J. L. McKimm-Breschkin, J. B. Caldwell, A. A. Kortt, and P. M. Colman. 1992. The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. Proteins 14:327-332.
44. von Itzstein, M., M. Wan Yang, and B. Jin. 1994. The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: a potent influenza virus sialidase inhibitor. Carbohydr. Res. 259:301-305.
45. von Itzstein, M., W.-Y. Wu, G. B. Kok, M. S. Pegg, J. C. Cyason, B. Jin, T. V. Phan, M. L. Smythe, H. F. White, S. W. Oliver, P. M. Colman, J. N. Varghese, D. M. Ryan, J. M. Woods, R. C. Bethell, V. J. Hotham, J. M. Cameron, and C. R. Penn. 1993. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363:418-423.
46. Williams, M. A., W. Lew, D. B. Mendel, C. Y. Tai, P. A. Escarpe, W. G. Laver, R. C. Stevens, and C. U. Kim. 1997. Structure-activity relationship of carbocyclic influenza neuraminidase inhibitors. Bioorg. Med. Chem. Lett. 7:1837-1842.
47. Woods, J. M., R. C. Bethell, J. A. V. Coates, N. Healy, S. A. Hiscox, B. A. Pearson, D. M. Ryan, J. Ticehurst, J. Tilling, S. M. Walcott, and C. R. Penn. 1993. 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneurammic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide ranee of influenza A and B viruses in vitro. Antimicrob. Agents Chemother. 37:1473-1479.